Navigation Links
New report estimates nearly 19 million cancer survivors in the US by 2024

ATLANTA June 1, 2014 The number of cancer survivors in the United States, currently estimated to be 14.5 million, will grow to almost 19 million by 2024, according to an updated report by the American Cancer Society. The second edition of Cancer Treatment & Survivorship Facts & Figures, 2014-2015 and an accompanying journal article published in CA: A Cancer Journal for Clinicians find that even though cancer incidence rates have been decreasing for ten years, the number of cancer survivors is growing. This is the result of increases in cancer diagnoses driven by the aging and growth of the population, as well as the fact that people are living longer with cancer because of earlier cancer detection and more effective treatments.

The three most common cancers among males living with a history of cancer in 2014 are prostate (43%), colorectal (9%), and melanoma (8%). Among women in 2014, the three most common cancers are breast (41%), uterine (8%), and colorectal (8%). While lung cancer is the leading cause of cancer death and the second most commonly diagnosed cancer in both men and women, a low survival rate makes it the number eight cancer site represented among survivors. The distribution of prevalent cancers is expected to be largely unchanged in 2024.

Other selected findings:

  • The majority of cancer survivors (64%) were diagnosed five or more years previously, and 15% were diagnosed 20 or more years ago.

  • Nearly one-half of cancer survivors (46%) are aged 70 years or older, while one in 20 (5%) is under age 40.

  • The age distribution of cancer survivors varies substantially by cancer type. For example, the majority of prostate cancer survivors (62%) are aged 70 and older, whereas less than one-third (32%) of melanoma survivors are in this age group.

  • By January 1, 2024, it is estimated that the population of cancer survivors will increase to nearly 19 million individuals (9.3 million males and 9.6 million females).

In addition to prevalence estimates, the reports also include data on cancer treatment patterns, survival, and information on common short- and long-term effects of cancer and its treatment for eleven selected cancers. Cancer Treatment and Survivorship Facts & Figures also contains sections on the effects of cancer and its treatment, impairment-driven cancer rehabilitation, palliative care, long term survivorship, the benefits of healthy behaviors, and resources for cancer survivors from the American Cancer Society and other organizations.

"The growing number of cancer survivors in the U.S. makes it increasingly important to understand the unique medical and psychosocial needs of survivors," said Carol DeSantis, MPH, American Cancer Society epidemiologist and lead author of the reports. "Despite the fact that awareness of survivorship issues has increased, cancer survivors face numerous, important hurdles created by a fractured health care system, poor integration of survivorship care, and financial and other barriers to quality care, particularly among the medically underserved. An important first step in addressing these challenges is to identify 'best practices' for the delivery of quality post-treatment cancer care."


Contact: David Sampson
American Cancer Society

Related medicine news :

1. Repeated sexual assault victims report more psychological problems than previously thought
2. Study finds outcome data in clinical trials reported inadequately, inconsistently
3. US cervical cancer rates higher than previously reported, especially among older women
4. WHI reports $37.1B economic return on combined hormone therapy clinical trial
5. Patients report high satisfaction with pain treatment
6. Twenty-five percent of breast cancer survivors report financial decline due to treatment
7. Patient requests for specific drugs have major impact on prescribing, reports study in Medical Care
8. Despite recession, childrens health spending increased between 2009-2012, says new report
9. Color vision problems become more common with age, reports Optometry and Vision Science
10. Patients with oropharyngeal cancer report quality of voice and speech affected post-treatment
11. Reducing RT dose to bilateral IB lymph nodes results in better patient-reported salivary function
Post Your Comments:
(Date:10/13/2015)... ... October 13, 2015 , ... ... development solutions for drugs, biologics, consumer health and animal health products, today announced ... will lead a new, dedicated global team of drug development and technology experts. ...
(Date:10/12/2015)... Nashville, TN (PRWEB) , ... October 13, 2015 ... ... the recipients of its biannual Heroes in Recovery Awards at Foundations Recovery Network’s ... Foundations Recovery Network presented the one-of-a-kind awards to Noah Levine and Dean Dauphinais ...
(Date:10/12/2015)... ... October 13, 2015 , ... North American Tool Corporation has been named ... National Meeting in Rosemont, IL on October 4th. , Each year, ... excellence that customers have come to expect from members of IBC’s marketing group. ...
(Date:10/12/2015)... ... ... of the “Check-In and Win a Vacation to Hawaii” Facebook contest at Gold’s Gym ... didn’t believe I could win a free vacation simply by checking in on Facebook every ... and invest in my own health – and now I’m going to Hawaii.” , Thanks ...
(Date:10/12/2015)... ... , ... Amerec , a leader in the steam and sauna industry, ... be displaying custom sauna and steam room solutions at the ISPA Conference & Expo ... customers, SpaEquip is recognized for their ability to assist in the design and implementation ...
Breaking Medicine News(10 mins):
(Date:10/12/2015)... Minn. , Oct. 12, 2015 Device ... a need to help integrate these devices into existing ... of ergonomic healthcare mounting and mobility solutions, has launched ... lightest cart yet, for a wide array of laptops ... Cart SV10 was developed exclusively for Microsoft Surface and ...
(Date:10/12/2015)... , October 12, 2015 ... Forecast to grow at 7.2% CAGR, microscopy ... by rising focus on nanotechnology, technological advancements, ... research report available with ... . --> Complete report ...
(Date:10/12/2015)... England , Oct. 12, 2015 Indivior PLC ... the District of Delaware granted the ... Teva Pharmaceuticals, Abbreviated New Drug Application (ANDA) No. 205299 to ... SUBOXONE® (buprenorphine and naloxone) Sublingual Film (CIII) in ... --> Since August 2013, Indivior has received Paragraph ...
Breaking Medicine Technology: